Sixteen 5,6-dihydro-2H-pyran-2-ones were evaluated in in vitro assay against trypomastigotes forms of Trypanosoma cruzi, the causative agent of Chagas' disease. A structure-activity relationship study (SAR) allowed us to establish the relevant structural features for the trypanocidal activity of goniothalamin analogues against T. cruzi. In fact, non-natural form of goniothalamin (ent-1) was threefold more potent than the natural one (1). In addition, we have identified analogues 9 and 10 (both displaying S configuration) as the highest potent compounds against T. cruzi with IC50=0.12 and 0.09 mM (IC50 value for crystal violet was 0.08 mM) whereas significantly lower toxicities were observed when these compounds were evaluated under LLC-MK2 ...
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people,...
The trypanocidal activity of several 3-(4'-bromo-[1,1-biphenyl]-4-yl) -3-(4-X-phenyl)-N,N-dimethyl-2...
The in vitro growth inhibition activity of new thiosemicarbazone derivatives against the protozoan p...
Sixteen 5,6-dihydro-2H-pyran-2-ones were evaluated in in vitro assay against trypomastigotes forms o...
The development of new drugs against Chagas disease is a priority since the currently available medi...
Hybrid compounds containing hydrazones and benzofuroxan pharmacophores were designed as potential Tr...
As a part of our project directed at the search of new chemotherapeutic agents against American tryp...
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thia...
Chagas disease is a neglected protozoan disease that affects more than eight million people in devel...
Chagas disease is one of the most important endemic diseases in Latin America, caused by Trypanosoma...
The natural lignans veraguensin and grandisin have been reported to be active against Trypanosoma cr...
Chagas disease, caused by <i>Trypanosoma cruzi</i> parasite, was described thousands of years ago. C...
Thirteen aminoalcohols and eight diamines were obtained and tested against Trypanosoma cruzi epimast...
We modified the thiazolidinic ring at positions N3, C4, and C5, yielding compounds 6-24. Compounds w...
Chagas disease, caused by Trypanosoma cruzi parasite, was described thousands of years ago. Currentl...
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people,...
The trypanocidal activity of several 3-(4'-bromo-[1,1-biphenyl]-4-yl) -3-(4-X-phenyl)-N,N-dimethyl-2...
The in vitro growth inhibition activity of new thiosemicarbazone derivatives against the protozoan p...
Sixteen 5,6-dihydro-2H-pyran-2-ones were evaluated in in vitro assay against trypomastigotes forms o...
The development of new drugs against Chagas disease is a priority since the currently available medi...
Hybrid compounds containing hydrazones and benzofuroxan pharmacophores were designed as potential Tr...
As a part of our project directed at the search of new chemotherapeutic agents against American tryp...
In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thia...
Chagas disease is a neglected protozoan disease that affects more than eight million people in devel...
Chagas disease is one of the most important endemic diseases in Latin America, caused by Trypanosoma...
The natural lignans veraguensin and grandisin have been reported to be active against Trypanosoma cr...
Chagas disease, caused by <i>Trypanosoma cruzi</i> parasite, was described thousands of years ago. C...
Thirteen aminoalcohols and eight diamines were obtained and tested against Trypanosoma cruzi epimast...
We modified the thiazolidinic ring at positions N3, C4, and C5, yielding compounds 6-24. Compounds w...
Chagas disease, caused by Trypanosoma cruzi parasite, was described thousands of years ago. Currentl...
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people,...
The trypanocidal activity of several 3-(4'-bromo-[1,1-biphenyl]-4-yl) -3-(4-X-phenyl)-N,N-dimethyl-2...
The in vitro growth inhibition activity of new thiosemicarbazone derivatives against the protozoan p...